Coronet Ventures Singapore is the Singaporean venture arm of Cedars-Sinai Intellectual Property Company (CSIP). We focus on identifying and investing in early-stage healthcare and biomedical science startups across Singapore.
Our mission is to support innovative solutions with strong potential for the U.S. healthcare market that align with Cedars-Sinai’s clinical and research priorities. By bridging Singaporean innovation with U.S. commercialization pathways, we accelerate the development of technologies that can transform patient care globally.